首页> 外文OA文献 >Day +11 Methotrexate (MTX) Might Reduce the Risk of Engraftment Syndrome (ES) and Acute Graft-Versus-Host Disease (GvHD) After Unrelated Bone Marrow Transplantation (U-BMT) With Reduced-Intensity Conditioning Regimens

【2h】

Day +11 Methotrexate (MTX) Might Reduce the Risk of Engraftment Syndrome (ES) and Acute Graft-Versus-Host Disease (GvHD) After Unrelated Bone Marrow Transplantation (U-BMT) With Reduced-Intensity Conditioning Regimens

机译：第11天+甲氨蝶呤（MTX）可通过强度降低的调理方案降低无关的骨髓移植（U-BMT）后的移植物综合征（ES）和急性移植物抗宿主病（GvHD）的风险

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yakushijin K.; Asakura Y.; Maeda T.; Kurosawa S.; Hiramoto N.; Kim S.-W.; Mori S.-I.; Tanosaki R.; Heike Y.; Takaue Y.; Tobinai K.; Fukuda T.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Methotrexate Reduces the Incidence of Severe Acute Graft-versus-Host Disease without Increasing the Risk of Relapse after Reduced-Intensity Allogeneic Stem Cell Transplantation from Unrelated Donors. [J] . Vigouroux S, Tabrizi R, Melot C, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2011,第1期

机译：甲氨蝶呤可降低严重急性移植物抗宿主病的发生率，而不会增加从无关供体进行强度降低的同种异体干细胞移植后复发的风险。
2. Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease. [J] . Kumar S, Wolf RC, Chen MG, Bone marrow transplantation . 2002,第3期

机译：异体骨髓移植后+11天甲氨蝶呤的遗漏会导致严重的急性移植物抗宿主病风险增加。
3. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. [J] . Valcarcel D, Martino R, Caballero D, Journal of Clinical Oncology . 2008,第4期

机译：降低强度的同种异体造血移植后，高危急性髓性白血病和骨髓增生异常综合症的持续缓解：慢性移植物抗宿主病是提高生存率的最强因素。
4. Anti-Thymocyte-Globulin (ATG-Fresenius) for Prevention of Acute and Chronic Graft-versus-Host Disease in Pediatric and Adult Recipients of Unrelated Donor Bone Marrow Transplantation [C] . . 2006

机译：抗胸腺细胞球蛋白（ATG-Fresenius）预防无关供体骨髓移植的小儿和成年患者的急性和慢性移植物抗宿主病
5. Advancing novel cell-based therapies for the prevention of graft versus host disease (GVHD) and improvement of engraftment following bone marrow transplantation. [D] . Highfill, Steven Lorenz. 2010

机译：推进基于细胞的新疗法，以预防移植物抗宿主病（GVHD）和改善骨髓移植后的移植物。
6. High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia — an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation [O] . Tomasz Czerw, Myriam Labopin, Christoph Schmid, 2016

机译：高强度CD3 +和CD34 +外周血干细胞移植物的含量与移植物抗宿主疾病的风险增加相关而对来自相关无关供体的急性髓样白血病的强度降低的同种异体移植强度降低后对疾病控制无有益影响-急性白血病的分析欧洲血液和骨髓移植学会工作组
7. High CD3+and CD34+peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia - an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation [O] . Czerw, Tomasz, Labopin, Myriam, Schmid, Christoph, 2016

机译：高强度的CD3 +和CD34 +外周血干细胞移植物与降低的适应性异体供体的异体异体异体移植强度降低后，对移植物抗宿主病的风险增加，而对疾病控制没有有益的影响-分析来自欧洲血液和骨髓移植学会急性白血病工作组

Day +11 Methotrexate (MTX) Might Reduce the Risk of Engraftment Syndrome (ES) and Acute Graft-Versus-Host Disease (GvHD) After Unrelated Bone Marrow Transplantation (U-BMT) With Reduced-Intensity Conditioning Regimens

著录项

相似文献

相关主题

期刊订阅